Top

Osteoporosis International

Published in:

01-08-2014 | Original Article

Suppressed bone turnover was associated with increased osteoporotic fracture risks in non-obese postmenopausal Chinese women with type 2 diabetes mellitus

Authors: R. Jiajue, Y. Jiang, O. Wang, M. Li, X. Xing, L. Cui, J. Yin, L. Xu, W. Xia

Published in: Osteoporosis International | Issue 8/2014

Abstract

Summary

We found that type 2 diabetes mellitus (T2DM) was associated with increased fracture risks in non-obese postmenopausal Chinese women, and suppressed bone turnover might be the underlying mechanism. This is the first study evaluating and explaining the association of T2DM with osteoporotic fracture in Chinese population with such high homogeneity.

Introduction

The aim of this study was to investigate the association of T2DM with osteoporotic fracture in postmenopausal Chinese women.

Methods

One thousand four hundred ten postmenopausal women were included and stratified into non-obese population [body mass index (BMI) < 25 kg/m²] and obese population (BMI ≥ 25 kg/m²). Each type of population was classified into diabetes group, impaired fasting glucose (IFG) group, and normal glucose group. Bone mineral density (BMD) was measured by dual-energy X-ray absorptiometry. Serum C-terminal telopeptide of type I collagen (β-CTX) and serum N-amino terminal prepeptide of type 1 procollagen (P1NP) were quantified. Vertebral fractures (VFs) and non-VFs were assessed by vertebral X-ray and questionnaire, respectively.

Results

Comparing to normal glucose group, diabetes group and IFG group both had lower levels of P1NP and β-CTX, despite population types. Despite having non-decreased BMD, non-obese diabetic patients had higher risks of total fracture and VF than BMI-matched normal glucose subjects (both P < 0.05). Non-obese population was further classified by a mean value of P1NP or β-CTX. Non-obese diabetic patients with low P1NP or high β-CTX had higher fracture risks (both P < 0.05), comparing to non-obese normal glucose subjects with high P1NP or high β-CTX, respectively.

Conclusions

Type 2 diabetic patients had suppressed bone turnover, which might explain the increased fracture risks, independent of BMD. IFG patients might also have poor bone quality and need early prevention.

Heath H, Melton LJ, Chu CP (1980) Diabetes mellitus and risk of skeletal fracture. N Engl J Med 303:567–570PubMedCrossRef

Forsen L, Meyer HE, Midthjell K, Edna TH (1999) Diabetes mellitus and the incidence of hip fracture: results from the Nord-Trondelag Health Survey. Diabetologia 42:920–925PubMed

Vestergaard P, Rejnmark L, Mosekilde L (2005) Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral anti-diabetic medication on relative fracture risk. Diabetologia 48:1292–1299PubMedCrossRef

Yamamoto M, Yamaguchi T, Yamauchi M, Kaji H, Sugimoto T (2009) Diabetic patients have an increased risk of vertebral fractures independent of bone mineral density or diabetic complications. J Bone Miner Res 24:702–709PubMedCrossRef

Tuominen JT, Impivaara O, Puukka P, Ronnemaa T (1999) Bone mineral density in patients with type 1 and type 2 diabetes. Diabetes Care 22:1196–1200PubMedCrossRef

Sosa M, Dominquez M, Navarro MC, Segarra MC, Hernandez D, de Pablos P, Betancor P (1996) Bone mineral metabolism is normal in non-insulin-dependent diabetes mellitus. J Diabetes Complicat 10:201–205PubMedCrossRef

van Daele PL, Stolk RP, Burger H, Algra D, Grobbee DE, Hofman A, Birkenhager JC, Pols HA (1995) Bone density in non-insulin-dependent diabetes mellitus: the Rotterdam Study. Ann Intern Med 122:409–414PubMedCrossRef

Sahin G, Bagis S, Cimen OB, Ozisik S, Guler H, Erdogan C (2001) Lumbar and femoral bone mineral density in type 2 Turkish diabetic patients. Acta Med (Hradec Kralove) 44:141–143

Yamamoto M, Yamaguchi T, Nawata K, Yamauchi M, Sugimoto T (2012) Decreased PTH levels accompanied by low bone formation are associated with vertebral fractures in postmenopausal women with type 2 diabetes. J Clin Endocrinol Metab 97:1277–1284PubMedCrossRef

10.

Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287:356–359PubMedCrossRef

11.

Gu D, Reynolds K, Wu X, Chen J, Duan X, Reynolds RF et al (2005) Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 365:1398–1405PubMedCrossRef

12.

Torrens JI, Skurnick J, Davidow AL, Korenman SG, Santoro N, Soto-Greene M et al (2004) Study of women’s health across the nation (SWAN). Ethnic differences in insulin sensitivity and beta-cell function in premenopausal or early premenopausal women without diabetes: the study of women’s health across the nation (SWAN). Diabetes Care 27:354–361PubMedCrossRef

13.

Zhou Y, Li Y, Zhang D, Wang J, Yang H (2010) Prevalence and predictors of osteopenia and osteoporosis in postmenopausal Chinese women with type 2 diabetes. Diabetes Res Clin Pract 90:261–269PubMedCrossRef

14.

Zhao J, Xia W, Nie M, Zheng X, Wang Q, Wang X, Wang W (2011) The levels of bone turnover markers in Chinese postmenopausal women: Peking Vertebral Fracture study. Menopause 18:1237–1243PubMedCrossRef

15.

Yudkin J (1983) Obesity: a report of the Royal College of Physicians. J R Coll Phys Lond 17:5–65

16.

Zhang ZH, Shen JX, Liu ZH (2005) Retrospective study on standardization of BMD machines in China. Chin J Osteoporos 11:133–145

17.

Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137–1148PubMedCrossRef

18.

Shu A, Yin MT, Stein E, Cremers S, Dworakowski E, Ives R, Rubin MR (2012) Bone structure and turnover in type 2 diabetes mellitus. Osteoporos Int 23:635–641PubMedCentralPubMedCrossRef

19.

Rasul S, Ilhan A, Wagner L, Luger A, Kautzky-Willer A (2012) Diabetic polyneuropathy relates to bone metabolism and markers of bone turnover in elderly patients with type 2 diabetes: greater effects in male patients. Gend Med 9:187–196PubMedCrossRef

20.

Mashiba T, Hirano T, Turner CH, Forwood MR, Johnston CC, Burr DB (2000) Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib. J Bone Miner Res 15:613–620PubMedCrossRef

21.

Botolin S, McCabe LR (2007) Bone loss and increased bone adiposity in spontaneous and pharmacologically induced diabetic mice. Endocrinology 148:198–205PubMedCrossRef

22.

Ferrer-Lorente R, Bejar MT, Tous M, Vilahur G, Badimon L (2013) Systems biology approach to identify alterations in the stem cell reservoir of subcutaneous adipose tissue in a rat model of diabetes: effects on differentiation potential and function. Diabetologia 57:246–256PubMedCrossRef

23.

Botolin S, McCabe LR (2006) Chronic hyperglycemia modulates osteoblast gene expression through osmotic and non-osmotic pathways. J Cell Biochem 99:411–424PubMedCrossRef

24.

Catalfamo D, Britten T, Storch D, Calderon N, Sorenson H, Wallet S (2013) Hyperglycemia induced and intrinsic alterations in type 2 diabetes-derived osteoclast function. Oral Dis 19:303–312PubMedCentralPubMed

25.

McCabe LR (2007) Understanding the pathology and mechanisms of type I diabetic bone loss. J Cell Biochem 102:1343–1357PubMedCrossRef

26.

de Paula FJ, Horowitz MC, Rosen CJ (2010) Novel insights into the relationship between diabetes and osteoporosis. Diabetes Metab Res Rev 26:622–630PubMedCentralPubMedCrossRef

27.

Barrera G, Bunout D, Gattas V, de la Maza MP, Leiva L, Hirsch S (2004) A high body-mass index protects against femoral neck osteoporosis in health elderly subjects. Nutrition 20:769–771PubMedCrossRef

28.

Felson DT, Zhang Y, Hannan MT, Anderson JJ (1993) Effects of weight and body mass index on bone mineral density in men and women: the Framingham study. J Bone Miner Res 8:567–573PubMedCrossRef

29.

Ravn P, Cizza G, Bjarnason NH, Thompson D, Daley M, Wasnich RD, McClung M, Hosking D, Yates AJ, Christiansen C (1999) Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women. Early Postmenopausal Intervention Cohort (EPIC) study group. J Bone Miner Res 14:1622–1627PubMedCrossRef

30.

Petit MA, Paudel ML, Taylor BC, Hughes JM, Strotmeyer ES, Schwartz AV et al (2010) Bone mass and strength in older men with type 2 diabetes: the Osteoporotic Fractures in Men Study. J Bone Miner Res 25:285–291PubMedCentralPubMedCrossRef

Title: Suppressed bone turnover was associated with increased osteoporotic fracture risks in non-obese postmenopausal Chinese women with type 2 diabetes mellitus
Authors: R. Jiajue
Y. Jiang
O. Wang
M. Li
X. Xing
L. Cui
J. Yin
L. Xu
W. Xia
Publication date: 01-08-2014
Publisher: Springer London
Published in: Osteoporosis International / Issue 8/2014
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-014-2714-5

At a glance: The STEP trials

Springer Medicine

Suppressed bone turnover was associated with increased osteoporotic fracture risks in non-obese postmenopausal Chinese women with type 2 diabetes mellitus

Abstract

Summary

Introduction

Methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Summary

Introduction

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 8/2014

Vitamin D and bisphosphonate response

Testosterone levels increase in association with recovery from acute fracture in men

A systematic review and meta-analysis of utility-based quality of life for osteoporosis-related conditions

Stress fracture of the ulna associated with bisphosphonate therapy and use of walking aid

Comparative statistical analysis of osteoporosis treatment based on Hungarian claims data and interpretation of the results in respect to cost-effectiveness

Interferon gamma (IFN-γ)-mediated inflammation and the kynurenine pathway in relation to risk of hip fractures: the Hordaland Health Study